These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8655729

  • 1. CD7-positive Sézary syndrome with a Th1 cytokine profile.
    Yagi H, Tokura Y, Furukawa F, Takigawa M.
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
    [Abstract] [Full Text] [Related]

  • 2. Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome).
    Vonderheid EC, Bigler RD, Kotecha A, Boselli CM, Lessin SR, Bernengo MG, Polansky M.
    J Invest Dermatol; 2001 Sep; 117(3):654-62. PubMed ID: 11564173
    [Abstract] [Full Text] [Related]

  • 3. Spontaneous IL-8 production by CD4(+), CD7(+) leukemia cells in erythrodermic Sézary syndrome.
    Ogawa F, Shimizu K, Hamasakia Y, Tanaka Y, Katayama I, Yamada Y, Tomonaga M.
    Leuk Lymphoma; 2002 May; 43(5):1061-6. PubMed ID: 12148887
    [Abstract] [Full Text] [Related]

  • 4. Immunophenotypic identification of Sezary cells in peripheral blood.
    Bogen SA, Pelley D, Charif M, McCusker M, Koh H, Foss F, Garifallou M, Arkin C, Zucker-Franklin D.
    Am J Clin Pathol; 1996 Dec; 106(6):739-48. PubMed ID: 8980349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A.
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
    Tokura Y, Yagi H, Ohshima A, Kurokawa S, Wakita H, Yokote R, Shirahama S, Furukawa F, Takigawa M.
    Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
    [Abstract] [Full Text] [Related]

  • 8. Expression of V beta gene segments by Sezary cells.
    Gorochov G, Bachelez H, Cayuela JM, Legac E, Laroche L, Dubertret L, Sigaux F.
    J Invest Dermatol; 1995 Jul; 105(1):56-61. PubMed ID: 7542297
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-7 is a growth factor for Sézary lymphoma cells.
    Dalloul A, Laroche L, Bagot M, Mossalayi MD, Fourcade C, Thacker DJ, Hogge DE, Merle-Béral H, Debré P, Schmitt C.
    J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
    [Abstract] [Full Text] [Related]

  • 11. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
    Seo N, Tokura Y, Matsumoto K, Furukawa F, Takigawa M.
    Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
    [Abstract] [Full Text] [Related]

  • 12. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK, Cassin M, Lessin SR, Rook AH.
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [Abstract] [Full Text] [Related]

  • 13. Dysregulation of lymphocyte interleukin-12 receptor expression in Sézary syndrome.
    Zaki MH, Shane RB, Geng Y, Showe LC, Everetts SE, Presky DH, Wysocka M, Moore JS, Rook AH.
    J Invest Dermatol; 2001 Jul; 117(1):119-27. PubMed ID: 11442758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.